PLoS ONE · 2016 · 12 citations · 25 references
MedicineInternal MedicineHepatologySurvival AnalysisTransplant SurgeryChronic Liver DiseaseHepatic Function TestingHepatic ImpairmentLiver CancerLiver DiseaseLiver TransplantationAllocationLiver Disease PrognosisMeld ScoreMortality RatesRefractory Ascites ManagementTransplant Waitlist ManagementWaiting List MortalityWaiting List Prioritization
BACKGROUND AND AIMS: MELD allocation system has changed the clinical consequences on waiting list (WL) for LT, but its impact on mortality has been seldom studied. We aimed to assess the ability of MELD and other prognostic scores to predict mortality after LT. METHODS: 301 consecutive patients enlisted for LT were included, and prioritized within WL by using the MELD-score according to: hepatic insufficiency (HI), refractory ascites (RA) and hepatocellular carcinoma (HCC). The analysis was performed to predict early mortality after LT (8 weeks). RESULTS: Patients were enlisted as HI (44.9%), RA (19.3%) and HCC (35.9%). The major aetiologies of liver disease were HCV (45.5%). Ninety-four patients (31.3%) were excluded from WL, with no differences among the three groups (p = 0.23). The remaining 207 patients (68.7%) underwent LT, being HI the most frequent indication (42.5%). HI patients had the shortest length within WL (113.6 days vs 215.8 and 308.9 respectively; p<0.001), but the highest early post-LT mortality rates (18.2% vs 6.8% and 6.7% respectively; p<0.001). The independent predictors of early post-LT mortality in the HI group were higher bilirubin (OR = 1.08; p = 0.038), increased iMELD (OR = 1.06; p = 0.046) and non-alcoholic cirrhosis (OR = 4.13; p = 0.017). Among the prognostic scores the iMELD had the best predictive accuracy (AUC = 0.66), which was strengthened in non-alcoholic cirrhosis (AUC = 0.77). CONCLUSION: Patients enlisted due to HI had the highest early post-LT mortality rates despite of the shortest length within WL. The iMELD had the best accuracy to predict early post-LT mortality in patients with HI, and thus it may benefit the WL management.
25
Model for end-stage liver disease (MELD) and allocation of donor livers
Russell H. Wiesner, Erick Edwards, Richard B. Freeman et al. · Gastroenterology · 2003 · 2.5K citations · Full text
Medicine, Biostatistics, Hepatology +13
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
W. Ray Kim, Scott W. Biggins, Walter K. Kremers et al. · New England Journal of Medicine · 2008 · 1.5K citations · Full text
Compensated cirrhosis: Natural history and prognostic factors
Pere Ginès, Enrique Quintero, Vicente Arroyo et al. · Hepatology · 1987 · 1.1K citations · Full text
Medicine, Pathology, Hepatology +16